甘化科工(000576) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥77,848,729.29, a decrease of 8.31% compared to ¥84,905,860.32 in the same period last year[3] - The net profit attributable to shareholders for Q1 2024 was ¥13,820,019.32, down 35.57% from ¥21,450,394.62 year-on-year[3] - The basic earnings per share decreased by 40.00% to ¥0.03 from ¥0.05 in the previous year[4] - Total operating revenue for Q1 2024 was CNY 77,848,729.29, a decrease of 8.8% compared to CNY 84,905,860.32 in Q1 2023[22] - Net profit for Q1 2024 was CNY 13,672,825.17, down 36.4% from CNY 21,378,484.39 in Q1 2023[23] - Earnings per share for Q1 2024 was CNY 0.03, compared to CNY 0.05 in the same period last year[23] Cash Flow - The net cash flow from operating activities improved significantly, reaching -¥6,116,427.18, a 92.46% increase compared to -¥81,087,607.43 in the same period last year[3] - The net cash flow from operating activities for Q1 2024 was -6,116,427.18, compared to -81,087,607.43 in Q1 2023, indicating an improvement[25] - Cash inflow from financing activities was 10,000,000.00, while cash outflow totaled 1,248,000.00, resulting in a net cash flow of 8,752,000.00, compared to -2,700,000.00 in Q1 2023[26] - The company reported a total cash outflow from operating activities of 107,245,653.73, slightly lower than 110,922,849.04 in the previous year[25] Assets and Liabilities - Total assets at the end of Q1 2024 were ¥1,856,914,625.30, reflecting a 0.82% increase from ¥1,841,724,750.08 at the end of the previous year[4] - The total liabilities as of Q1 2024 were CNY 211,477,312.32, compared to CNY 209,130,888.43 in Q1 2023[21] - Total equity increased to CNY 1,645,437,312.98 from CNY 1,632,593,861.65 year-over-year[21] - The company's total current assets amount to 887,104,899.02 yuan, an increase from 853,749,802.65 yuan at the beginning of the period[19] Expenses - Total operating costs increased to CNY 65,069,836.08, up 6.8% from CNY 61,375,123.45 in the previous year[22] - The company experienced a 53.58% reduction in selling expenses, totaling ¥2,288,763.73 compared to ¥4,931,076.77 in the previous year[11] - Research and development expenses rose to CNY 18,750,970.74, an increase of 9.6% from CNY 17,108,328.96 in the previous year[22] Investments - Investment payments increased to ¥372,000,000.00, a 163.64% rise from ¥141,100,000.00 in the previous year, primarily due to increased purchases of financial products[12] - The company recorded a government subsidy income of ¥4,148,703.55, contributing to the increase in other income[6] Shareholder Information - The total number of common shareholders at the end of the reporting period is 30,133[15] - Delixi Group Co., Ltd. holds 42.47% of shares, totaling 186,087,400 shares, with 70,499,999 shares pledged and 30,000,000 shares frozen[15] Future Outlook - Future outlook includes a focus on market expansion and potential new product development to drive revenue growth[22]